InterCure Ltd (INCR) has fallen Wednesday morning, with the stock falling -7.65% in pre-market trading to 1.57. INCR's short-term technical score of 3 indicates that the stock has traded less bullishly over the last month than 97% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 133 out of 146 industries, the stock ranks higher than 12% of stocks. InterCure Ltd has fallen 11.92% over the past month, closing at $2.05 on June 7. During this period of time, the stock fell as low as $1.70 and as high as $2.22. INCR has an average analyst recommendation of Strong Buy. The company has an average price target of $5.00.
News Home
InterCure Ltd has a Long-Term Technical rank of 3. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 97% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 136 by this metric, INCR ranks better than 136% of stocks.
InterCure Ltd (INCR) Down 7.65% in Premarket Trading
Mentioned in this article
INCR has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on INCR!